VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3147
ETF rank
ยฃ12.28 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ16.61
Share price
-0.15%
Change (1 day)
1.34%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of January 2026: 0.35%